Image courtesy of the U.S. Centers for Disease Control. Over the past 50 years, survival rates for a group of blood cancers known as myelodysplastic syndrome (MDS) have not improved, despite the ...

Personalized treatment strategies are increasingly important in managing lung cancer brain metastases, incorporating targeted therapies and immunotherapies. Stereotactic radiosurgery and whole-brain ...

Racial and Ethnic Disparities in Receipt of Guideline-Concordant Pancreatic Cancer Care Among Older Adults in the United States Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases ...

Purpose Myelodysplastic syndromes (MDS) are classified as de novo and therapy-related (tMDS). We evaluated associations between MDS risk factors separately for de novo and tMDS. Methods The study ...

Outpatient care for MDS patients can improve mental health and quality of life, reducing caregiver strain and hospital stays. Celiac disease is associated with increased risks for various cancers, ...

Receiving a myelodysplastic syndromes (MDS) diagnosis isn’t easy, and talking with your family about it can feel overwhelming. Here’s what you need to know to answer some of the most common questions.

While infections pose a risk for morbidity and mortality among patients with MDS, more needs to be studied about the topic, researchers urged. Patients with myelodysplastic syndromes (MDS) may ...

A new national study shows for the first time that people exposed to Agent Orange face a higher risk of developing myelodysplastic syndrome (MDS), tend to develop it earlier, and often have more ...

An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence for patients with MDS. Reblozyl (luspatercept) has become the new standard ...

“This study has been a personal quest,” said Mikkael Sekeres, M.D., chief of hematology at Sylvester Comprehensive Cancer Center. “I see veterans who develop these conditions and need expensive ...